Dr. Leonard Donato Amoruso, DO

Dr. Amoruso practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Amoruso's NPI, 1457676355, was assigned on April 2, 2010. Dr. Amoruso graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2010. Dr. Amoruso holds New York license 269335.

Dr. Amoruso's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Amoruso's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Amoruso is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Amoruso to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amoruso practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Amoruso's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Amoruso is board certified in internal medicine by the American Board of Internal Medicine. Dr. Amoruso is licensed in New York.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, cerebrovascular disease, chronic anemia, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Amoruso treats.

CMS data shows 492 Medicare services from Dr. Amoruso across 4 procedure codes in 2024, for 265 Medicare patients. Medicare paid $27,287 for them.

CMS counts 265 Medicare patients who saw Dr. Amoruso in 2024. The largest group is 65 to 74, with 120 patients. 69% of them have high blood pressure, and 67% have high cholesterol. 58% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amoruso's median patient age at 62, with 59% women.

In 2024, Dr. Amoruso wrote 18,205 Medicare Part D claims for 1,682 patients. 82% of them were for generic drugs. CMS names the drug for 17,281 of them, across 209 drugs with 11 or more claims each, at $1,987,963 in total drug cost. In 2023, CMS named 13,786 claims across 184 drugs.

Dr. Amoruso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amoruso as offering telehealth.

Dmand AI links 2 papers to Dr. Amoruso. The most frequent topics are Diabetic Nephropathies. Dr. Amoruso has published most often in J Prim Care Community Health. Dr. Amoruso's most frequent co-authors are Steven G. Coca, DO, MS, Girish Nitin Nadkarni, MD and Joji Erik Tokita, MD.

CMS Open Payments shows 5 general payments to Dr. Amoruso from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 53% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $22.

Dr. Amoruso graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2010.

Dr. Amoruso is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.